Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kathy Harvey

Pediatrics Logan, WV Doctor of Osteopathy

NPI 1720036817 CMS profile 123691

258 Hanging Rock Hwy, Logan, WV 25601

Open in the dashboard

General payments

$184

10 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kathy Harvey of Logan, WV is reported in the CMS Open Payments database as having received $184 across 10 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 48th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $88 4
2023 General $14 1
2021 General $68 4
2019 General $14 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kathy Harvey
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Kathy Harvey were reported at $88. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Kathy Harvey Pediatrics median Middle half National median
2019 $14 $86 $31–$183 $163
2020 $0 $49 $22–$110 $114
2021 $68 $68 $27–$158 $132
2022 $0 $77 $30–$173 $149
2023 $14 $88 $33–$190 $160
2024 $0 $94 $34–$206 $164
2025 $88 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Novartis Pharmaceuticals Corporation $51 3 payments
  2. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $50 2 payments
  3. Smith+Nephew, Inc. $38 2 payments
  4. Novo Nordisk Inc $17 1 payment
  5. Mylan Specialty L.P. $14 1 payment
  6. Kestra Medical Technology Services, Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $184 10 payments
Products named General payments · program years 2019–2025
  1. ENTRESTO $51 3 payments
  2. LifeVest $50 2 payments
  3. COLLAGENASE SANTYL $38 2 payments
  4. RYBELSUS $17 1 payment
  5. Ozempic $17 1 payment
  6. Yupelri $14 1 payment
  7. Assure WCD $14 1 payment
  8. Iodosorb Ointment 40g USA $14 1 payment
  9. REGRANEX $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 45 drugs

Part D claims

1,346

Median for Hospitalist: 109

Drug cost

$39,674

Median for Hospitalist: $6,399

Branded share of claims

15.4%

Median for Hospitalist: 19.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 36 $18,203
Januvia Sitagliptin Phosphate Brand 16 $11,137
Daptomycin Generic 12 $2,109
Midodrine Hcl Generic 12 $683
Methylprednisolone Generic 63 $516
Cefdinir Generic 41 $453
Amiodarone Hcl Generic 26 $386
Isosorbide Mononitrate Er Isosorbide Mononitrate Brand 57 $367
Spironolactone Generic 36 $362
Levothyroxine Sodium Generic 65 $335

The 10 drugs with the highest cost, of 45 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,498 Part D prescribers listed as Hospitalist; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$60,602

Medicare's payments for the services billed

Medicare patients

203

Average age 73

Services billed

667

110 women, 93 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 64%
Diabetes 57%
Chronic kidney disease 56%
Arthritis 55%
COPD 52%
Heart failure 49%
Depression 42%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

10 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record